From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
Groups | OSR (%) | PFS (month) | OS (month) |
---|---|---|---|
The control group (n = 78) | 65 (83.33) | 8.82 ± 2.65 | 14.26 ± 2.79 |
The observation group (n = 80) | 72 (90.00) | 10.98 ± 2.52 | 18.56 ± 3.25 |
t value | 1.523 | 5.251 | 8.914 |
P value | 0.217 | < 0.001 | < 0.001 |